Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/2012
06/21/2012WO2012080149A1 Novel benzofurane compounds
06/21/2012WO2012079721A1 Terpenoid spiro ketal compounds with lxr agonists activity, their use and formulations with them
06/21/2012WO2012054739A3 Structure-guided identification of binding interactions of human laminin receptor precursor with laminin and identification of compounds that affect binding
06/21/2012WO2012051601A3 Heteroarylthio compounds
06/21/2012WO2012051213A3 Therapeutic 5,6,5-tricyclic analogs
06/21/2012WO2012050944A9 Methods of treating chronic prostatitis/chronic pelvic pain syndrome
06/21/2012WO2012050380A3 Novel pyridyl benzoxazine derivatives, pharmaceutical composition comprising the same, and use thereof
06/21/2012WO2012034101A3 Expandable cell source of neuronal stem cell populations and methods for obtaining and using them
06/21/2012WO2012028961A3 Compositions and methods for treating friedreich's ataxia with interferon gamma
06/21/2012US20120157976 Methods for treating neurological conditions and compositions and materials therefor
06/21/2012US20120157937 Transdermal therapeutic system provided with improved long-term carrying comfort
06/21/2012US20120157549 Methods of preventing, treating and diagnosing disorders of protein aggregation
06/21/2012US20120157544 Process for the Preparation of O-Desmethyl Venlafaxine and Intermediate for Use Therein
06/21/2012US20120157541 Soluble pharmaceutical formulations of n,n-diaminodiphenyl sulfone for optimal use in the treatment of various diseases
06/21/2012US20120157539 Nuclear receptor binding agents
06/21/2012US20120157537 NMDA receptor antagonists and their use in inhibiting abnormal hyperphosphorylation of microtubule associated protein tau
06/21/2012US20120157536 Composition for transdermal administration of non-steroidal anti-flammatory drug
06/21/2012US20120157532 Method Of Treating Or Preventing A Convulsive Disorder In A Patient In Need Thereof
06/21/2012US20120157526 Treatment of portal hypertension and restoration of liver function using l-ornithine phenylacetate
06/21/2012US20120157524 3-methanesulfonylpropionitrile for treating inflammation and pain
06/21/2012US20120157523 Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use
06/21/2012US20120157516 Novel thiophene compounds for use in therapy
06/21/2012US20120157515 Methods and compositions for the treatment of "Burning Feet Syndrome"
06/21/2012US20120157506 Novel Imidazole-2-Benzamide Compounds Useful for the Treatment of Osteoarthritis
06/21/2012US20120157502 Phenanthrenone compounds, compositions and methods
06/21/2012US20120157501 Isoketal scavengers and mitigation of disorders involving oxidative injury
06/21/2012US20120157494 Isoindolyl compounds
06/21/2012US20120157490 N-biarylamides
06/21/2012US20120157477 Reversal of l-dopa-induced dyskinesia by neuronal nicotinic receptor ligands
06/21/2012US20120157475 Combination Preparation Against Vertigo
06/21/2012US20120157469 Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof
06/21/2012US20120157464 Use of azabicycloalkyl derivatives or pyrrolidine-2-one derivatives for the treatment or prevention of ataxia
06/21/2012US20120157463 Chromone derivatives, a process for their preparation and their therapeutic applications
06/21/2012US20120157460 Tetrahydro-azacarboline mch-1 antagonists, methods of making, and uses thereof
06/21/2012US20120157458 Imidazotriazinone compounds
06/21/2012US20120157454 Isoquinolin-1 (2h) -one derivatives as parp-1 inhibitors
06/21/2012US20120157453 Raf inhibitor compounds and methods of use thereof
06/21/2012US20120157450 Anhydrate Forms Of A Pyridine Derivative
06/21/2012US20120157449 Benzofurane compounds
06/21/2012US20120157448 Compounds for treating neurodegenerative diseases
06/21/2012US20120157445 Cognitive Function
06/21/2012US20120157440 Novel fused pyridine compounds as casein kinase inhibitors
06/21/2012US20120157438 Pyranyl aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators
06/21/2012US20120157437 Vla-4 inhibitory drug
06/21/2012US20120157436 5,6,7,8-TETRAHYDRO[1,2,4]TRIAZOLO[4,3-a]PYRAZINE DERIVATIVES AS P2X7 MODULATORS
06/21/2012US20120157430 N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors
06/21/2012US20120157429 Compounds useful as inhibitors of janus kinases
06/21/2012US20120157427 Pyrazole aminopyrimidine derivatives as lrrk2 modulators
06/21/2012US20120157420 Treatment and prevention of secondary injury after trauma or damage to the central nervous system
06/21/2012US20120157419 Methods and compositions for treating alzheimer's disease
06/21/2012US20120157412 Substituted Pyrimidinyl Oxime Kinase Inhibitors
06/21/2012US20120157411 2-amino-4-arylthiazole compounds as trpai antagonists
06/21/2012US20120157410 Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
06/21/2012US20120157407 Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
06/21/2012US20120157405 Methods and Compositions for the Treatment of "Burning Feet Syndrome"
06/21/2012US20120157403 Bicyclic and tricyclic derivatives as thrombin receptor antagonists
06/21/2012US20120157401 Methods for treating neurofibromatosis
06/21/2012US20120157393 Biopolymer, implant comprising it and uses thereof
06/21/2012US20120157392 Epilepsy treatment employing ketogenic compounds which arrest apoptosis
06/21/2012US20120157386 Neprilysin inhibitors
06/21/2012US20120157385 Cyclosporin conjugates
06/21/2012US20120157382 Pharmaceutical glp-1 compositions having an improved release profile
06/21/2012US20120157371 High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds
06/21/2012US20120156305 Methods for enhancing genome stability and telomere elongation in embryonic stem cells
06/21/2012US20120156290 Process for preparing oxymorphone, naltrexone, and buprenorphine
06/21/2012US20120156264 Injectable depot formulation comprising crystals of iloperidone
06/21/2012US20120156260 Prodrugs Containing an Aromatic Amine Connected By an Amido Bond to a Linker
06/21/2012US20120156244 Nasal Compositions and Uses Thereof
06/21/2012US20120156234 Means for treating synucleinopathies
06/21/2012US20120156230 Treatment of spinal cord injury and traumatic brain injury using placental stem cells
06/21/2012US20120156222 Prevention and treatment of alzheimer's disease
06/21/2012US20120156221 Method and Pharmaceutical Composition for Use in the Treatment of Neurodegenerative Disorders
06/21/2012US20120156219 Nitrogen-containing heterocyclic compounds and medicinal use thereof
06/21/2012US20120156193 Antibodies That Specifically Bind to A Beta Oligomers and Use Thereof
06/21/2012US20120156180 Compositions and methods for the treatment of krabbe and other neurodegenerative diseases
06/21/2012US20120156175 Composition for inducing migration of neural stem cells containing periostin as effective ingredient
06/21/2012US20120156164 In situ-forming hydrogel for tissue adhesives and biomedical use thereof
06/21/2012US20120156138 Methods and Compositions for the Treatment of Medical Conditions Involving Cellular Reprogramming
06/21/2012CA2821893A1 Pyrazole derivative
06/21/2012CA2821818A1 Treatment of spinal cord injury and traumatic brain injury using placental stem cells
06/21/2012CA2821244A1 Therapeutic agent for disc herniation
06/21/2012CA2820924A1 Method for suppressing an immune response
06/21/2012CA2819970A1 Novel benzofurane compounds
06/21/2012CA2819171A1 New compounds for the treatment of neurodegenerative diseases
06/21/2012CA2818903A1 Casein kinase 1delta (ck1delta) inhibitors
06/20/2012EP2465859A1 8-Triazolylxanthine derivatives, processes for their production and their use as adenosine receptor antagonists
06/20/2012EP2465850A1 Therapeutic compounds
06/20/2012EP2465524A1 Autoantibody production inhibitor
06/20/2012EP2465504A1 Novel 2,3-diamino-quinazolinone derivatives and their medical use
06/20/2012EP2465501A1 (2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms, and methods of preparation
06/20/2012EP2465500A1 Therapeutically effective amounts of R(+) and S(-) pramipexole for use in the treatment of parkinson's disease
06/20/2012EP2465499A2 Therapeutic agent for treating pain
06/20/2012EP2464667A2 N-acylated octasaccharides activating fgfs receptors, their synthesis and their therapeutical application
06/20/2012EP2464653A2 Method for making 3 -hydroxy, 3 - methyl-5 -pregnan-20-one (ganaxolone)
06/20/2012EP2464640A1 Inhibitors of jnk
06/20/2012EP2464639A1 Pyrimidone derivatives used as tau protein kinase 1 inhibitors
06/20/2012EP2464632A1 Pyrimidone derivatives used as tau protein kinase 1 inhibitors
06/20/2012EP2464629A1 Selective sphingosine-1-phosphate receptor antagonists
06/20/2012EP2464376A1 Method for repairing neurodegeneration
06/20/2012EP2464359A2 N-sulfated oligosaccharides activating fgfs receptors, their synthesis and their therapeutical application
1 ... 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 ... 1833